Effects of PF-04620110, a novel diacylglycerol acyltransferase 1 (DGAT-1) inhibitor, in type 2 diabetes (T2DM) subjects with insufficient glycemic control on metformin

Authors
Category Primary study
ConferenceDiabetes
Year 2012
This article has no abstract
Epistemonikos ID: 8e03a4591de37dc6dd8807f9324fad4bf01a6ce9
First added on: Apr 30, 2026